Perrery Farmaceutici S.r.l.

HELICOТER

Helicobacter pylori is a small spiral-shaped gram-negative bacterium. It infected more than 60% of the world's population, but for many people it does not manifest itself. The uniqueness of this microorganism lies in its ability to dwell in one of the most aggressive environments of the body - in the acidic conditions of the stomach.

Barry Marshall, Professor of Clinical Microbiology at the University of Western Australia, proved for the first time that gastric ulcer is in most cases caused by H. pylori, for which he received the 2005 Nobel Prize in Medicine and Physiology. For many years, the only way to treat diseases caused by H. pylori was eradication - that is, the complete removal from the body of this bacterium with antibiotics. But later it turned out that the complete eradication of H. pylori can lead to serious diseases: gastroesophageal reflux disease, asthma and esophageal adenocarcinoma.

How to reduce the number of H. pylori but at the same time not increase the risk of serious diseases? HELICOТЕR - OPTIMAL SOLUTION!

Helicoter is a new approach in treatment of patients with H. pylori infection. Helicoter contains a free-flowing powder obtained through fermentation and spray-drying of Lactobacillus reuteri DSM 17648, which has a specific anti-helicobacter effect. It specifically binds and aggregates the stomach bacterium Helicobacter pylori. Thanks to this unique mode of action, Helicoter helps to reduce the bacterial load of H. pylori in the stomach. The result is a necessary reduction in the level of Helicobacter pylori which helps to prevent the recurrence of chronic diseases of the gastrointestinal tract, and also prevents the appearance of diseases of the stomach and duodenum.